EUCTR2006-002805-30-IT进行中（未招募）不适用
Strategic long term, immunologically driven treatment interruptions in previously naive patients starting HAART: a controlled, randomized, multicenter study - (Therapeutic Structured Interruptions Study)
AZIENDA OSPEDALIERA OSPEDALI RIUNITI DI BERGAMO (A.O. DI RILIEVO NAZIONALE)0 个研究点开始时间: 2007年6月19日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •a. Inclusion i. Age > 18 years ii. Informed consent signed iii. Being naive for ARV therapy iv. CD4 cell count nadir and current CD4 count > 200 cells/L
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •i. Childbearing or breastfeeding. Women of childbearing potential will be asked to adopt effective contraceptive methods or behaviors ii. Any ongoing grade 4 laboratory abnormality iii. Previous diagnosis of AIDS iv. Active HBV co-infection v. Previous HIV-related AEs such as, but not limited to thrombocytopenia (platelets < 10.000/L)
研究者
相似试验
招募中
2 期
An immune-therapeutic salvage strategy for ‘functional’ high-risk (FHR) multiple myeloma incorporating Iberdomide, Isatuximab, and Dexamethasone (Iber-IsaDex) – the IBIS studyBlood - Haematological diseasesMultiple MyelomaACTRN12621001037897Australasian Myeloma Research Consortium50
进行中（未招募）
不适用
A Long Term Safety and Effectiveness Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)HPVMedDRA version: 18.1Level: LLTClassification code 10063001Term: Human papilloma virus infectionSystem Organ Class: 100000004862EUCTR2014-005717-23-Outside-EU/EEAMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.1,575
尚未招募
不适用
An integrated immunological-pharmacological approach to improve long-term allograft functiograft failurekidney transplantation10029149NL-OMON45414Inwendige Geneeskunde - Nefrologie en Transplantatie420
进行中（未招募）
1 期
Stopping treatment along with immune therapy in patients with HIV + who have already been treated with stem cells from each blood cells are formedEUCTR2019-001461-32-ESIrsiCaixa AIDS Research Institute
已完成
2 期
1E10 anti-idiotype vaccine, metastatic colon, phase II.Colon adenocarcinoma phase IV or evolvable metastatic diseaseColonic NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesColorectal NeoplasmsRPCEC00000006Center of Molecular Immunology (CIM)40